Market Closed -
Bombay S.E.
11:00:47 14/05/2024 BST
|
5-day change
|
1st Jan Change
|
1,066
INR
|
+2.07%
|
|
-6.13%
|
+76.71%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,019
|
1,733
|
1,180
|
2,814
|
7,022
|
5,847
|
Enterprise Value (EV)
1 |
4,573
|
3,692
|
3,052
|
4,197
|
8,470
|
7,720
|
P/E ratio
|
-42.6
x
|
-51.9
x
|
6.89
x
|
-30.3
x
|
13.3
x
|
9.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.43
x
|
0.31
x
|
0.22
x
|
0.45
x
|
0.6
x
|
0.4
x
|
EV / Revenue
|
0.96
x
|
0.66
x
|
0.56
x
|
0.68
x
|
0.73
x
|
0.52
x
|
EV / EBITDA
|
15.5
x
|
10
x
|
6.47
x
|
7.9
x
|
8.3
x
|
6.87
x
|
EV / FCF
|
77.7
x
|
11.8
x
|
141
x
|
11.9
x
|
-29.4
x
|
-13.5
x
|
FCF Yield
|
1.29%
|
8.47%
|
0.71%
|
8.38%
|
-3.4%
|
-7.42%
|
Price to Book
|
5.35
x
|
2.7
x
|
1.37
x
|
3.31
x
|
5.03
x
|
2.88
x
|
Nbr of stocks (in thousands)
|
11,931
|
13,731
|
13,731
|
15,031
|
15,031
|
15,067
|
Reference price
2 |
169.2
|
126.2
|
85.90
|
187.2
|
467.2
|
388.0
|
Announcement Date
|
04/09/18
|
31/08/19
|
08/09/20
|
02/09/21
|
30/08/22
|
29/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
4,741
|
5,589
|
5,444
|
6,215
|
11,658
|
14,729
|
EBITDA
1 |
295.6
|
367.6
|
471.4
|
531.6
|
1,020
|
1,124
|
EBIT
1 |
205.4
|
277
|
379.4
|
405.4
|
893.4
|
982.5
|
Operating Margin
|
4.33%
|
4.96%
|
6.97%
|
6.52%
|
7.66%
|
6.67%
|
Earnings before Tax (EBT)
1 |
-45.95
|
20.74
|
172.9
|
259.1
|
734.2
|
722.1
|
Net income
1 |
-47.37
|
-30.17
|
171.7
|
-92.96
|
535.9
|
621.4
|
Net margin
|
-1%
|
-0.54%
|
3.15%
|
-1.5%
|
4.6%
|
4.22%
|
EPS
2 |
-3.972
|
-2.430
|
12.47
|
-6.186
|
35.25
|
40.86
|
Free Cash Flow
1 |
58.85
|
312.6
|
21.67
|
351.7
|
-288.3
|
-572.6
|
FCF margin
|
1.24%
|
5.59%
|
0.4%
|
5.66%
|
-2.47%
|
-3.89%
|
FCF Conversion (EBITDA)
|
19.91%
|
85.03%
|
4.6%
|
66.16%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
12.62%
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
04/09/18
|
31/08/19
|
08/09/20
|
02/09/21
|
30/08/22
|
29/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
2,555
|
1,959
|
1,873
|
1,383
|
1,448
|
1,873
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
8.64
x
|
5.33
x
|
3.973
x
|
2.602
x
|
1.42
x
|
1.667
x
|
Free Cash Flow
1 |
58.9
|
313
|
21.7
|
352
|
-288
|
-573
|
ROE (net income / shareholders' equity)
|
-11.9%
|
-5.92%
|
21.7%
|
-9.55%
|
48.6%
|
30.8%
|
ROA (Net income/ Total Assets)
|
3.02%
|
4.19%
|
5.67%
|
5.88%
|
10%
|
9%
|
Assets
1 |
-1,570
|
-720.9
|
3,028
|
-1,580
|
5,345
|
6,906
|
Book Value Per Share
2 |
31.60
|
46.70
|
62.70
|
56.60
|
93.00
|
135.0
|
Cash Flow per Share
2 |
5.760
|
2.470
|
1.350
|
4.300
|
4.240
|
2.930
|
Capex
1 |
63.4
|
71.5
|
194
|
69.5
|
234
|
198
|
Capex / Sales
|
1.34%
|
1.28%
|
3.57%
|
1.12%
|
2.01%
|
1.34%
|
Announcement Date
|
04/09/18
|
31/08/19
|
08/09/20
|
02/09/21
|
30/08/22
|
29/08/23
|
|
1st Jan change
|
Capi.
|
---|
| +16.91% | 66.18B | | +1.64% | 49.24B | | +16.70% | 41.72B | | +22.44% | 26.16B | | +12.92% | 19.75B | | +2.79% | 17.5B | | -23.54% | 15.63B | | -6.24% | 15.46B | | +2.52% | 15.43B |
Other Specialty Chemicals
|